BofA analyst Rock Hoffman resumed coverage of Sigma Lithium (SGML) with a Buy rating and $12 price target While the firm’s price target implies “significant 95% upside” from the current share price, it remains spodumene market price sensitive, the analyst tells investors. If the firm were to take a more bearish stance that spodumene prices don’t see recovery until 2028, the effect on its net asset value would be “material,” albeit still in Buy territory, the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGML:
- Optimistic Outlook for Sigma Lithium: Buy Rating Based on Strategic Growth Potential and Market Dynamics
- Sigma Lithium Reports Strong Production Amid Revenue Dip
- Sigma Lithium Achieves Production Targets Amid Strategic Sales Withholding
- Sigma Lithium Streamlines Leadership and Announces Shareholder Meeting Results
- Sigma Lithium announces consolidation of core leadership roles